Immunohematology Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Immunohematology 
Market Research and 
Forecast Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a te s t  r e p o r t  b y  I M A R C  Gr o u p ,  t i t l e d  " Im m u n o h e m at o l o g y  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  i mm u no h e ma t o l o g y  m a rk e t  s i ze  r e a ch e d  U S $  1 . 9  B i l l i o n  i n  20 2 3 .
Fac tors  A f fec t ing  the  Growth  o f  t he  Immunohemat o logy  Indus t ry :
Report Increas ing  Preva lence  o f  B lood- re la ted  D isorders :T he  r i s i n g  p r e va l e n c e  o f  b l o o d - r e l a t e d  d i s o r d e rs  s u c h  a s  an e m i a ,  h e m op h i l i a ,  a n d  
l e u ke m i a  s i gn i f i c a n t l y  d r i v e s  t he  i mm u no h e ma t o l o g y  m a r k e t .  W i t h  a n  i n c re a s i n g  nu m b e r  
Highlight and o f  p a t i e n ts  d i a g n os e d  w i t h  t h e s e  co n d i t i o ns ,  t h e r e  i s  a  g r ow i n g  ne e d  f o r  ad v a n c ed  d i a gn o s t i c  t o o l s  t o  ma n a g e  a n d  t r ea t  b l o od  d i so r d e r s  e f f e c t i v e l y .  I m mu n o h em a t o l og y  
p r o v i d e s  c r u c i a l  s e r v i c e s  s u ch  a s  b l oo d  t y p i n g ,  c ro s s - ma t c h i ng ,  a n d  a n t i bo d y  
Description sc r e e n i n g ,  w h i c h  a r e  e s s e n t i a l  f o r  a c c u ra t e  d i a g n o s i s  a n d  sa f e  t r an s f u s i on  p ra c t i c e s .  
E a r l y  d e t ec t i o n  t h ro u g h  t h e se  a d v a nc e d  t e c h n i q u e s  c a n  s i g n i f i c an t l y  i m p r ov e  p a t i e n t  
ou t c o me s  a nd  r e du c e  t h e  r i s k  o f  co m p l i c a t i o n s .  A s  h ea l t h c a re  p r o v i d e r s  f oc u s  m o r e  on  
p r e c i s i o n  me d i c i n e ,  t h e  d e ma n d  f o r  s o p h i s t i c a t e d  i m m u no h e ma t o l o g y  s o l u t i o ns  
co n t i n u e s  to  g r o w ,  d r i v i n g  m a rk e t  e x p an s i o n .  T h i s  t r e n d  u nd e r s co r e s  t h e  i m p o r t a n c e  o f  
i mm u n oh e m a t o l o g y  i n  m od e r n  h e a l t h c a r e ,  e sp e c i a l l y  as  t h e  g l o b a l  b u r d e n  o f  b l o o d -
r e l a t e d  d i s e a s es  c o n t i nu e s  to  r i s e .
Advancements in  Technology and Automat ion:
Techno log ica l  advancement s  and au t om at i on  in  immunohemato logy  a re  ma jo r  
marke t  d r ive rs .  I nnova t ions  such  as  au tomat ed  b lood  t yp ing  and c ross -ma t ch ing  
sys tems have  revo lu t ion i zed  b lood t es t ing  p rocesses  by  enhanc ing  accu racy ,  
Report ef f i c iency ,  and  speed .  Au tomat ion  reduces  t he  r i sk  o f  human  er ro r ,  ensur ing  h igher  r e l i ab i l i t y  i n  b lood  t es t  r esu l t s ,  wh ich  i s  c r i t i ca l  f o r  pa t ien t  sa fe t y  dur ing  
t r ans fus ions  and  t r ea tm en ts .  
Highlight and These  techno log ies  a lso  s t reaml ine  labora t o r y  work f lows ,  i nc reas ing  p roduc t i v i t y  
and  a l low ing  fo r  h ighe r  t h roughput  in  b lood  t es t i ng .  The  con t inuous  deve lopm en t  
Description of  t hese  techno log ies ,  i nc lud ing  in t eg ra t i on  w i t h  labo ra to ry  i n f o rmat ion  sys tems (L IS )  and  t he  use  o f  advanced  so f t ware ,  f u r t he r  p rope ls  marke t  g rowth ,  m ak ing  
immunohemato logy  an  in t eg ra l  pa r t  o f  modern  d iagnos t i c  and  t herapeut i c  
p rocedures .
Growing Number o f  Blood Donat ions and Transfusions:
The  inc reas ing  number  o f  b lood  dona t i ons  and  t rans f us ions  wor ldw ide  
s i gn i f i can t l y  f ue ls  t he  immunohemato logy  m arke t .  B lood t r ans f us ions  a re  c r i t i ca l  
f o r  su rger ies ,  t r auma ca re ,  and  t r ea t ing  var ious  med ica l  cond i t i ons ,  necess i t a t ing  
p rec ise  b lood  ma tch ing  and  sc reen ing  to  ensu re  compa t i b i l i t y  and  sa fe ty .
Immunohemato logy  p lays  a  v i t a l  ro le  in  th is  p rocess  by  p rov id ing  essen t ia l  
se rv ices  such  as  b lood  t yp ing ,  an t ibody  de tec t ion ,  and  c ross -match ing ,  wh ich  
a re  c ruc ia l  fo r  p reven t ing  t rans fus ion  reac t ions .  As  hea l thcare  sys tems 
g loba l ly  see  a  r i se  in  su rg ica l  p rocedures  and  t rea tments  requ i r i ng  
t rans fus ions ,  the  demand fo r  re l i ab le  immunohemato logy  p roduc ts  and  
se rv ices  inc reases .  Add i t iona l l y ,  pub l i c  hea l th  in i t ia t i ves  and  awareness  
campa igns  p romot ing  b lood  dona t ion  con t r ibu te  to  the  g rowing  supp ly ,  wh ich  in  
Report tu rn  requ i res  met icu lous  tes t ing  and  management ,  f u r the r  d r i v ing  the  marke t .  
Th is  t rend  h igh l igh ts  the  essen t ia l  ro le  o f  immunohemato logy  in  ensur ing  sa fe  
and  e f fec t i ve  b lood  t rans fus ions .
Highlight and 
Request  for  a  PDF sample  o f  th is  repor t :  
Description h t tps : / /www. imarcgroup .com/ immunohemato logy-marke t / reques tsamp le
Report Description
Global  Immunohematology Market  Trends:
The g loba l  immunohemato logy  marke t  i s  p r ima r i l y  d r i ven  by  the  inc reas ing  p reva lence  o f  b lood- re la ted  d iso rders  
such  as  anemia ,  hemoph i l ia ,  and  leukemia  s ign i f i can t ly  wh ich  has  augmenetd  the  demand fo r  advanced  
d iagnos t ic  t oo ls  and  the rap ies ,  as  ear ly  and  accura te  de tec t ion  i s  c ruc ia l  fo r  e f fec t ive  t rea tmen t .  Add i t i ona l ly ,  
ongo ing  advancemen ts  in  techno logy  and  au tomat ion ,  such  as  au tomated  b lood  t yp ing  and  c ross -match ing  
sys tems,  enhance  the  accuracy ,  e f f i c iency ,  and  speed  o f  b lood  tes t ing  p rocesses ,  reduc ing  human  e r ro r  and  
improv ing  pa t ien t  sa fe ty ,  t hus  p rope l l ing  marke t  g rowth .  
Th is  techno log ica l  p rogress  makes immunohemato logy  too ls  more  a t t rac t i ve  to  hea l thca re  p rov ide rs  seek ing  to  
s t reaml ine  opera t ions  and  improve  se rv i ce  qua l i t y .  Fur the rmore ,  t he  g row ing  number  o f  b lood  dona t ions  and  
t rans fus ions  wor ldwide  is  f ue l ing  marke t  g rowth ,  as  these  p rocedures  a re  essen t ia l  i n  su rger ies ,  t rauma care ,  and  
t rea tment  o f  va r ious  med ica l  cond i t i ons ,  necess i ta t ing  p rec ise  b lood  match ing  and  sc reen ing  to  ensure  sa fe ty  and  
compat ib i l i t y .
View Repor t  TOC,  F igures  and  Tables :  h t tps: / /www. imarcgroup.com/ immunohemato logy-market
Breakup by Product:
• Analyzing Systems
• Reagents and Consumables
Breakup by Technology:
• Biochips
• Gel Cards
Report 
• Microplates
Segmentation • Polymerase Chain React ion
• Erythrocyte-Magnetized Technology (EMT)
• Others
Breakup by Application:
• Blood-Related Diseases
• HIV
• Hepati t is
• Blood Transfusion
• Others
Breakup by End-User:
• Hospita ls
• Blood Banks
Report • Diagnost ic  Laborator ies
• Others
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle East  and Afr ica
• Abbott
• Antisel
• BD (Becton Dickinson and Company)
• Beckman Coulter Inc.  (Danaher Corporation)
Competitive 
• Bio-Rad Laboratories Inc.
Landscape • Hoff mann-La Roche Ltd.
with Key • Grifols S.A.
• Merck KGaA
Players
• MTC Invitro Diagnostics AG
• Ortho-Clinical  Diagnostics Inc (The Carlyle 
Group)
• Siemens Healthcare GmbH
• Thermo Fisher Scientifi c Inc
How has the global immunohematology market 
performed so far and how will it perform in the coming 
years?
What are the key regional markets?
Key What has been the impact of COVID-19 on the global 
immunohematology market?
Questions 
Answered in What is the breakup of the market based on the product?
the Report
What is the breakup of the market based on the 
technology?
What is the breakup of the market based on the 
application?
What is the breakup of the market based on the end-
user?
What are the various stages in the value chain of the 
industry?
What are the key driving factors and challenges in the 
industry?
Key What is the structure of the global immunohematology 
market and who are the key players?
Questions 
Answered in What is the degree of competition in the industry?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  I m m u n o h e m a t o l o g y  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     A n a l y z i n g  S y s t e m s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     R e a g e n t s  a n d  C o n s u m a b l e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     B i o c h i p s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     G e l  C a r d s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     M i c r o p l a t e s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     P o l y m e r a s e  C h a i n  R e a c t i o n
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     E r y t h r o c y t e - M a g n e t i z e d  T e c h n o l o g y  ( E M T )
        7 . 5 . 1  M a r k e t  T r e n d s
Table of         7 . 5 . 2  M a r k e t  F o r e c a s t
    7 . 6     O t h e r s
        7 . 6 . 1  M a r k e t  T r e n d s
Contents         7 . 6 . 2  M a r k e t  F o r e c a s t8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     B l o o d - R e l a t e d  D i s e a s e s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     H I V
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     H e p a t i t i s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     B l o o d  T r a n s f u s i o n
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m / i m m uno h ema t o lo gy-m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: